Role of thrombophilic factors in full-term infants with neonatal encephalopathy

Pediatric Research

Volumn 73, Issue 1, 2013, Pages 80-86

  Harteman, Johanna C ^a   Groenendaal, Floris ^a   Benders, Manon Jnl ^a   Huisman, Albert ^b   Blom, Henk J ^c   De Vries, Linda S ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; HOMOCYSTEINE; LIPOPROTEIN A; PROTHROMBIN;

AMINO ACID BLOOD LEVEL; ARTICLE; BASAL GANGLION; BRAIN DISEASE; DNA POLYMORPHISM; FEMALE; GENE; GENE MUTATION; GENOTYPE; HUMAN; HYPOGLYCEMIA; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INFANT; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEONATAL ENCEPHALOPATHY; NEUROIMAGING; NEWBORN; NEWBORN DISEASE; PERINATAL PERIOD; PRENATAL PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; WHITE MATTER INJURY;

APGAR SCORE; BASAL GANGLIA DISEASES; FACTOR V; HOMOCYSTEINE; HUMANS; HYPOGLYCEMIA; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; LEUKOENCEPHALOPATHIES; LIPOPROTEIN(A); MAGNETIC RESONANCE IMAGING; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; PROTHROMBIN; RISK FACTORS;

EID: 84872073040     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2012.150     Document Type: Article

References (40)

1. Pierrat V, Haouari N, Liska A, Thomas D, Subtil D, Truffert P. Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy: population based study. Arch Dis Child Fetal Neonatal Ed 2005;90:F257-61.
2. Ferriero DM. Neonatal brain injury. N Engl J Med 2004;351:1985-95.
3. de Vries LS, Groenendaal F. Patterns of neonatal hypoxic-ischaemic brain injury. Neuroradiology 2010;52:555-66.
4. Cowan F, Rutherford M, Groenendaal F, et al. Origin and timing of brain lesions in term infants with neonatal encephalopathy. Lancet 2003;361:736-42.
5. Li AM, Chau V, Poskitt KJ, et al. White matter injury in term newborns with neonatal encephalopathy. Pediatr Res 2009;65:85-9.
6. Mercuri E, Rutherford M, Barnett A, et al. MRI lesions and infants with neonatal encephalopathy. Is the Apgar score predictive? Neuropediatrics 2002;33:150-6.
7. Miller SP, Ramaswamy V, Michelson D, et al. Patterns of brain injury in term neonatal encephalopathy. J Pediatr 2005;146:453-60.
8. Leviton A, Dammann O. Coagulation, inflammation, and the risk of neonatal white matter damage. Pediatr Res 2004;55:541-5.
9. Calkavur S, Akisu M, Olukman O, et al. Genetic factors that influence short-term neurodevelopmental outcome in term hypoxic-ischaemic encephalopathic neonates. J Int Med Res 2011;39:1744-56.
10. Myers RE. Four patterns of perinatal brain damage and their conditions of occurrence in primates. Adv Neurol 1975;10:223-34.
11. Nadeem M, Murray DM, Boylan GB, Dempsey EM, Ryan CA. Early blood glucose profile and neurodevelopmental outcome at two years in neonatal hypoxic-ischaemic encephalopathy. BMC Pediatr 2011;11:10.
12. Salhab WA, Wyckoff MH, Laptook AR, Perlman JM. Initial hypoglycemia and neonatal brain injury in term infants with severe fetal acidemia. Pediatrics 2004;114:361-6.
13. Burns CM, Rutherford MA, Boardman JP, Cowan FM. Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatrics 2008;122:65-74.
14. Anwar M, Vannucci RC. Autoradiographic determination of regional cerebral blood flow during hypoglycemia in newborn dogs. Pediatr Res 1988;24:41-5.
15. Yager JY, Heitjan DF, Towfighi J, Vannucci RC. Effect of insulin-induced and fasting hypoglycemia on perinatal hypoxic-ischemic brain damage. Pediatr Res 1992;31:138-42.
16. Hagberg H, Gilland E, Bona E, et al. Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr Res 1996;40:603-9.
17. Bauman ME, Cheung PY, Massicotte MP. Hemostasis and platelet dysfunction in asphyxiated neonates. J Pediatr 2011;158(2 Suppl):e35-9.
18. Adhami F, Liao G, Morozov YM, et al. Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy. Am J Pathol 2006;169:566-83.
19. El Beshlawy A, Hussein HA, Abou-Elew HH, Abdel Kader MS. Study of protein C, protein S, and antithrombin III in hypoxic newborns. Pediatr Crit Care Med 2004;5:163-6.
20. Dodelson de Kremer R, Grosso C. Maternal mutation 677CT in the methylenetetrahydrofolate reductase gene associated with severe brain injury in offspring. Clin Genet 2005;67:69-80.
21. Kenet G, Lkhoff LK, Albisetti M, et al. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation 2010;121:1838-47.
22. Ramenghi LA, Fumagalli M, Groppo M, et al. Germinal matrix hemorrhage: intraventricular hemorrhage in very-low-birth-weight infants: the independent role of inherited thrombophilia. Stroke 2011;42: 1889-93.
23. Lievers KJ, Boers GH, Verhoef P, et al. A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk. J Mol Med 2001;79:522-8.
24. Troen AM. The central nervous system in animal models of hyperhomocysteinemia. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:1140-51.
25. van der Put NM, Blom HJ. Neural tube defects and a disturbed folate dependent homocysteine metabolism. Eur J Obstet Gynecol Reprod Biol 2000;92:57-61.
26. Kloppenborg RP, Nederkoorn PJ, van der Graaf Y, Geerlings MI. Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMART-MR study. Atherosclerosis 2011;216:461-6.
27. Endres M, Ahmadi M, Kruman I, Biniszkiewicz D, Meisel A, Gertz K. Folate deficiency increases postischemic brain injury. Stroke 2005;36:321-5.
28. Refsum H, Grindflek AW, Ueland PM, et al. Screening for serum total homocysteine in newborn children. Clin Chem 2004;50:1769-84.
29. Hogeveen M, den Heijer M, Schonbeck Y, et al. The effect of folinic acid supplementation on homocysteine concentrations in newborns. Eur J Clin Nutr 2010;64:1266-71.
30. Molloy AM, Mills JL, McPartlin J, Kirke PN, Scott JM, Daly S. Maternal and fetal plasma homocysteine concentrations at birth: the influence of folate, vitamin B12, and the 5, 10-methylenetetrahydrofolate reductase 677C-T variant. Am J Obstet Gynecol 2002;186:499-503.
31. Gther G, Junker R, Strer R, et al. ; Childhood Stroke Study Group. Symptomatic ischemic stroke in full-term neonates: role of acquired and genetic prothrombotic risk factors. Stroke 2000;31:2437-41.
32. Simchen MJ, Goldstein G, Lubetsky A, Strauss T, Schiff E, Kenet G. Factor v Leiden and antiphospholipid antibodies in either mothers or infants increase the risk for perinatal arterial ischemic stroke. Stroke 2009;40:65-70.
33. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood 1987;70:165-72.
34. Thompson CM, Puterman AS, Linley LL, et al. The value of a scoring system for hypoxic ischaemic encephalopathy in predicting neurodevelopmental outcome. Acta Paediatr 1997;86:757-61.
35. Epelman M, Daneman A, Kellenberger CJ, et al. Neonatal encephalopathy: a prospective comparison of head US and MRI. Pediatr Radiol 2010;40:1640-50.
36. de Vries LS, Cowan FM. Evolving understanding of hypoxic-ischemic encephalopathy in the term infant. Semin Pediatr Neurol 2009;16:216-25.
37. Barkovich AJ, Miller SP, Bartha A, et al. MR imaging, MR spectroscopy, and diffusion tensor imaging of sequential studies in neonates with encephalopathy. AJNR Am J Neuroradiol 2006;27:533-47.
38. Nowak-Gtl U, Junker R, Hartmeier M, et al. Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. Circulation 1999;100:743-8.
39. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995;74:1185-90.
40. Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009;7:1737-40.